PACB Jan 2024 32.000 call
| Previous Close | 5.0000 |
| Open | 5.0000 |
| Bid | 2.1500 |
| Ask | 6.9000 |
| Strike | 32.00 |
| Expire Date | 2024-01-19 |
| Day's Range | 5.0000 - 5.0000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 3 |
- GlobeNewswire
PacBio Collaborates with iLAC and Robotic Biology Institute to Develop Automated Workflows
Advanced Automation Aims to Optimize Service Lab Efficiency and Highly Reproducible Data Production from HiFi Long-Read SequencingMENLO PARK, Calif., TOKYO, May 09, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced a collaboration with genome analysis company iLAC, Inc. (iLAC) and Robotic Biology Institute, Inc. (RBI) to develop fully automated end-to-end workflows for PacBio’s Sequel II and Sequel IIe HiFi
- GlobeNewswire
PacBio to Participate in the BofA Securities 2022 Healthcare Conference
MENLO PARK, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- PacBio announced today that it will be participating in the upcoming BofA Securities 2022 Healthcare Conference in Las Vegas, Nevada. PacBio’s management is scheduled to present on Thursday, May 12 at 11:20 a.m. Pacific Time / 2:20 p.m. Eastern Time. The live webcast can be accessed at the company’s investors page at investor.pacificbiosciences.com. A replay of the webcast will be available for at least 30 days following the presentation. Abou
- Zacks
PacBio's (PACB) Q1 Earnings Miss Estimates, Revenues Beat
PacBio (PACB) sees strength in Q1 segmental revenues, led by robust consumable and instrument sales.
